Rubraca (Clovis Oncology, Inc.)
Welcome to the PulseAid listing for the Rubraca drug offered from Clovis Oncology, Inc.. This Poly(ADP-Ribose) Polymerase Inhibitor [EPC],Poly(ADP-Ribose) Polymerase Inhibitors [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Clovis Oncology, Inc. |
| NON-PROPRIETARY NAME: | rucaparib |
| SUBSTANCE NAME: | RUCAPARIB CAMSYLATE |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Poly(ADP-Ribose) Polymerase Inhibitor [EPC],Poly(ADP-Ribose) Polymerase Inhibitors [MoA] |
| ROUTE: | ORAL |
| DOSAGE FORM: | TABLET, FILM COATED |
| MARKETING CATEGORY NAME: | NDA |
| START MARKETING DATE: | 2016-12-19 |
| END MARKETING DATE: | 0000-00-00 |
Rubraca HUMAN PRESCRIPTION DRUG Details:
| Item Description | Rubraca from Clovis Oncology, Inc. |
| LABELER NAME: | Clovis Oncology, Inc. |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 200(mg/1) |
| START MARKETING DATE: | 2016-12-19 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 69660-201_acb1cfd2-6ab1-4051-921c-225718e1f10f |
| PRODUCT NDC: | 69660-201 |
| APPLICATION NUMBER: | NDA209115 |
Other RUCAPARIB CAMSYLATE Pharmaceutical Manufacturers / Labelers:
